The Ineffectiveness of New Jersey's Tax Breaks for Pharmaceutical Companies: A Closer Look at Healthcare Affordability and Economic Strain

By: Stephen N Zielinski Sr

Published on: 18/07/2024

This article examines how New Jersey's tax breaks for pharmaceutical companies fail to make healthcare affordable and strain residents economically. It highlights the need for policy reassessment to balance economic growth and healthcare affordability.